外体非编码RNAs:癌症和癌症干细胞之间的交叉介质
Shuangmin Wang1, Jiaojiao Shu2,3, Nuoxin Wang4,5,6
1Department of Immunology, Zunyi Medical University, Zunyi, Guizhou Province, China.
Cell death discovery
|October 6, 2025
概括
携带非编码RNA (ncRNA) 的外体细胞介导癌症干细胞 (CSC) 和其他瘤细胞之间的通信,促进癌症的进展和治疗耐药性. 针对这些外体ncRNAs提供了一种破坏促进瘤循环和治疗恶性瘤的策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 瘤含有癌症干细胞 (CSC) 和差异化非CSC.
- 外体细胞在瘤微环境 (TME) 中介于CSC和非CSC之间的通信.
- 外体内非编码RNAs (ncRNAs) 是瘤过程的关键媒介.
研究的目的:
- 阐明外体ncRNAs在CSCs和非CSCs之间的双向通信中的作用.
- 了解这种沟通如何影响瘤的进展和治疗阻力.
主要方法:
- 对PubMed索引的研究进行系统的文献分析.
- 专注于外体ncRNA及其对TME内的CSC和非CSC的影响.
主要成果:
- 非CSC外体ncRNAs可以增强CSC的干性.
- 来自CSC的外体ncRNAs促进非CSC的干性,转移,血管新生,化学抵抗和免疫抑制.
- 外体ncRNA显示出作为液体活检生物标志物和治疗点的潜力.
结论:
- 外体ncRNAs在TME中充当沟通桥梁,促进一个促进瘤的循环.
- 向外体ncRNAs可以破坏CSC-非CSC交叉,可能延迟瘤的进展.
- 这些发现支持开发针对耐治疗癌症的组合策略.
更多相关视频
相关概念视频
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
Regulation of Hematopoietic Stem Cells
4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
Mesenchymal Stem Cells
5.5K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.5K
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K


